Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // September 10th, 2007 // 7:12 am
A new week gets under way. And so this is an opportunity to catch up on events. Here are some worth noting….
Lundbeck Looking To Buy Other Companies In US (AFX/Thomson Financial)
Actavis Makes FDA Filing Challenging King Patent (MarketWatch)
India May Add More Drugs To Price-Controlled List (The Economic Times)
Teva Must Stop Selling Generic Famvir (Bloomberg News)
Cipla Sales Hurt By NGOs (BusinessWeek)